Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma

References

• Stein H, Uchanska-Ziegler B, Gerdes J, Ziegler A. Wernet, P. Hodgkin and Reed – Sternberg cells contain antigens specific to late cells of granulopoiesis. Int J Cancer 1982; 29: 283–290
   PubMed Web of Science ®Google Scholar
• Stein H, Mason D Y, Gerdes J, O'Conner N, Wainscoat J, Pallesen G. The expression of the Hodgkin's disease-associated antigen Ki-1 in reactive neoplastic lymphoid tissue: evidence that Reed – Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858
   PubMed Web of Science ®Google Scholar
• Pinkus G S, Said J W. Hodgkin's disease, lymphocyte predominance type, nodular—further evidence for a B cell derivation. L & H variants of Reed – Sternberg cells express L26, a pan B cell marker. Am J Pathol 1988; 133: 211–217
   PubMed Web of Science ®Google Scholar
• Tamaru J, Mikata A, Azuma K, Takagi T. Reciprocal/dichotomic expression of vimentin and B-cell differentiation antigens in Reed – Sternberg's cells. Virchows Arch [A] 1990; 416: 213–220
   Web of Science ®Google Scholar
• Foss H D, Reusch R, Demel G, Lenz G, Anagnostopoulos I, Hummel M, et al. Frequent expression of the B-cell specific activator protein in Reed – Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood 1999; 94: 3108–3113
   PubMed Web of Science ®Google Scholar
• Torlakovic E, Tierens A, Dang H D, Delabie J. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol 2001; 159: 1807–1814
   PubMed Web of Science ®Google Scholar
• Torlakovic E, Torlakovic G, Nguyen P L, Brunning R D, Delabie J. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker. Am J Surg Pathol 2002; 26: 1343–1350
   PubMed Web of Science ®Google Scholar
• Tamaru J, Hummel M, Zemlin M, Kalvelage B, Stein H. Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. Blood 1994; 84: 708–715
   PubMed Web of Science ®Google Scholar
• Yatabe Y, Oka K, Asai J, Mori N. Poor correlation between clonal immunoglobulin rearrangement and immunoglobulin gene transcription in Hodgkin's disease. Am J Pathol 1996; 149: 1351–1361
   PubMed Web of Science ®Google Scholar
• Marafioti T, Hummel M, Anagnostopoulos I, Foss H D, Falini B, Delsol G, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 1997; 337: 453–458
   PubMed Web of Science ®Google Scholar
• Kueppers R, Klein U, Hansmann M L, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999; 341: 1520–1529
   PubMed Web of Science ®Google Scholar
• Marafioti T, Hummel M, Foss H D, Laumen H, Korbjuhn P, Anagnostopoulos I, et al. Hodgkin and Reed – Sternberg cells represent an expansion of single clone originating from germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443–1450
   PubMed Web of Science ®Google Scholar
• Stein H, Marafioti T, Foss H D, Laumen H, Hummel M, Anagnostopoulos I, et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001; 97: 496–501
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. Pathology and Genetic of Tumours of Hemetopoietic and Lymphoid Tissues. IARC, LyonFrance 2001
   Google Scholar
• Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 1995; 86: 1954–1960
   PubMed Web of Science ®Google Scholar
• Foss H D, Anagnostopoulos I, Araujo I, Assaf C, Demel G, Kummer J A, et al. Anaplastic large cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996; 88: 4005–4011
   PubMed Web of Science ®Google Scholar
• Krenacs L, Wellmann A, Sorbara L, Himmelmann A W, Bagdi E, Jaffe E S, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997; 89: 980–989
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Stein H, Banks P M, Chan J K, Cleary M L, et al. A revised European – American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Stein H, Foss H D, Duerkop H, Marafioti T, Delsol G, Pulford K, et al. CD30+ anaplastic lymphoma: a review of its histopathologic, genetic and clinical futures. Blood 2000; 96: 3681–3695
   PubMed Web of Science ®Google Scholar
• Jaffe E S. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol 2001; 14: 219–228
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. The World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues. Ann Oncol 1999; 10: 1419–1432
   PubMed Web of Science ®Google Scholar
• Cazals-Hatem D, Andre M, Mounier N, Copin M C, Divine M, Berger F, et al. Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87) A GELA Study. Am J Surg Pathol 2001; 25: 297–306
   PubMed Web of Science ®Google Scholar
• Browne P, Petrosyan K, Hernandez A, Chan J A. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am J Clin Pathol 2003; 120: 767–777
   PubMed Web of Science ®Google Scholar
• Garcia-Cosio M, Santon A, Martin P, Camarasa N, Montalban C, Garcia J F, et al. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. Mod Pathol 2004; 17: 1531–1538
   PubMed Web of Science ®Google Scholar
• Seitz V, Hummel M, Marafioti T, Anagnostopoulos I, Assaf C, Stein H. Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed – Sternberg cells of classic Hodgkin disease. Blood 2000; 95: 3020–3024
   PubMed Web of Science ®Google Scholar
• Brousset P, Rochaix P, Chittal S, Rubie H, Robert A, Delsol G, et al. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993; 23: 189–191
   PubMed Web of Science ®Google Scholar
• van den Berg A, Maggio E, Rust R, Kooistra K, Diepstra A, Poppema S. Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. Blood 2002; 100: 1425–1429
   PubMed Web of Science ®Google Scholar
• Herling M, Rassidakis G Z, Jones D, Schmitt-Graeff A, Sarris A H, Medeiros J. Absence of Epstein-Barr virus in anaplastic large cell lymphoma: A study of 64 cases classified according to World Health Organization criteria. Hum Pathol 2004; 35: 455–459
   PubMed Web of Science ®Google Scholar
• Loddenkemper C, Anagnostopoulos I, Hummel M, Johrens-Leder K, Foss H D, Jundt F, et al. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol 2004; 202: 60–69
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne R D, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B-cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198: 851–862
   PubMed Web of Science ®Google Scholar
• Savage K J, Monti S, Kutok J L, Cattoretti G, Neuberg D, De Leval L, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102: 3871–3879
   PubMed Web of Science ®Google Scholar
• Steimle-Grauer S A, Tinguely M, Seada L, Fellbaum C, Hansmann M L. Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma. Virchows Arch 2003; 442: 284–293
   PubMed Web of Science ®Google Scholar
• Kanzler H, Kueppers R, Hansmann M L, Rajewsky K. Hodgkin and Reed – Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495–1505
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Martelli M, Magagnoli M, Zaccaria A, Ronconi F, Cantonetti M, et al. Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood 1998; 92: 790–794
   PubMed Web of Science ®Google Scholar
• Vanhentenrijk V, Vanden Bempt I, Dierickx D, Verhoef G, Wlodarska I, De Wolf-Peeters C. Relationship between classic Hodgkin lymphoma and overlapping large cell lymphoma investigated by comparative expressed sequence hybridization expression profiling. J Pathol 2006; 210: 155–162
   PubMed Web of Science ®Google Scholar